Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | DPP4 | P27487 | 2/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | MC4R | P32245 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | FAP | Q12884 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL240405 | 1.00 | ALDH1A1 (0.62) | ALDH1A1MMP2MEN1KMT2ALMNA | |
| SCHEMBL4367409 | 1.00 | ALDH1A1 (0.62) | ALDH1A1MMP2MEN1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL4371678 | 0.98 | ALDH1A1 (0.64) | ALDH1A1MMP2MEN1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL1230535 | 0.98 | ALDH1A1 (0.64) | ALDH1A1MMP2MEN1KMT2ALMNA | |
| Hydrochloric Acid SCHEMBL240404 | 0.98 | ALDH1A1 (0.64) | ALDH1A1MMP2MEN1KMT2ALMNA | |
| SCHEMBL27546222 | 0.98 | ALDH1A1 (0.61) | ALDH1A1MMP2MEN1KMT2ALMNA | |
| SCHEMBL8211198 | 0.93 | ALDH1A1 (0.56) | ALDH1A1MMP2MEN1KMT2ADPP4 | |
| SCHEMBL4097192 | 0.93 | ALDH1A1 (0.56) | ALDH1A1MMP2MEN1KMT2ADPP4 | |
| SCHEMBL11651148 | 0.88 | MMP2 (0.49) | ALDH1A1MMP2LMNADPP4DPP7 | |
| SCHEMBL1859542 | 0.87 | MAPT (0.50) | ALDH1A1MMP2LMNADPP4DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260001924-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | NEW YORK UNIVERSITY (US) | 2026-01-01 | — | — | US | disclosed |
| US-12371461-B2 | Nemo coiled coil mimics and methods of using same | NEW YORK UNIVERSITY (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4541378-A2 | COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | Endocyte, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| EP-3777898-B1 | COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | ENDOCYTE INC (US) | 2025-01-01 | — | — | EP | disclosed |
| US-12178892-B2 | Compounds for positron emission tomography | PURDUE RESEARCH FOUNDATION (US) | 2024-12-31 | — | — | US | disclosed |
| WO-2024145483-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND METHODS OF MAKING AND USING THE SAME | HTG MOLECULAR DIAGNOSTICS, INC. (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240190930-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | UNIV NEW YORK (US) | 2024-06-13 | — | — | US | disclosed |
| WO-2024097355-A1 | DEUBIQUITINASE-TARGETING CHIMERAS AND RELATED METHODS | VICINITAS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| US-11891422-B2 | NEMO coiled coil mimics and methods of using same | NEW YORK UNIVERSITY (US) | 2024-02-06 | — | — | US | disclosed |
| US-20240025846-A1 | ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS | ACAD PHARMACEUTICALS INC (US) | 2024-01-25 | — | — | US | disclosed |
| EP-0484989-B1 | Polysubstituted diethylenetriamine chelates for forming a metal-chelate-protein conjugate | GANSOW OTTO A (US) | 1996-04-24 | — | — | EP | disclosed |
| EP-0587134-A2 | Cyclic urea derivatives, medicaments containing them and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1994-03-16 | — | — | EP | disclosed |
| WO-1994003593-A1 | AMPLIFIER MOLECULES FOR ENHANCEMENT OF DIAGNOSIS AND THERAPY | THE STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1994-02-17 | — | — | WO | disclosed |
| EP-0328529-B1 | METHOD FOR PREPARING POLYSUBSTITUTED DIETHYLENETRIAMINEPENTAACETIC ACIDS | GANSOW OTTO A (US) | 1994-01-26 | — | — | EP | disclosed |
| US-5246692-A | Diagnostic, theraputic | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES (US) | 1993-09-21 | — | — | US | disclosed |
| EP-0529645-A1 | Process for the preparation of backbone polysubstituted chelates. | GANSOW, Otto A. (US) | 1993-03-03 | — | — | EP | disclosed |
| EP-0484989-A1 | Polysubstituted diethylenetriamine chelates for forming a metal-chelate-protein conjugate | GANSOW, Otto A. (US) | 1992-05-13 | — | — | EP | disclosed |
| US-5099069-A | Radioactive materials for diagnosis and treatment of tumors and cancer by joining monoclonal antibodies | GANSOW OTTO A (US) | 1992-03-24 | — | — | US | disclosed |
| US-4831175-A | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1989-05-16 | — | — | US | disclosed |
| US-4622420-A | Chelating agents and method | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1986-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12371461-B2 | Nemo coiled coil mimics and methods of using same | COIL, CALCOCO2, NCAPH | ALDH1A1 3890/4885MMP2 4776/4885MEN1 200/4885 |
| US-20240025846-A1 | ULTRA SHORT ACTING ANTI-ARRHYTHMIC AGENTS | CACNA1G, SCN5A, CACNA1F | ALDH1A1 1515/4885MMP2 4140/4885MEN1 4508/4885 |
| US-12178892-B2 | Compounds for positron emission tomography | FOLH1, FOLR2, FOLR1 | ALDH1A1 2485/4885MMP2 3053/4885MEN1 259/4885 |
| US-20260001924-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | DDX21, PHAX, RBX1 | ALDH1A1 4748/4885MMP2 4688/4885MEN1 2283/4885 |
| US-11891422-B2 | NEMO coiled coil mimics and methods of using same | COIL, CALCOCO2, NCAPH | ALDH1A1 3890/4885MMP2 4776/4885MEN1 200/4885 |
| US-20240190930-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | COIL, CALCOCO2, NCAPH | ALDH1A1 3702/4885MMP2 4799/4885MEN1 144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.